We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLSD
526
DELISTED
Clearside Biomedical
CLSD
| $2.78M | 0.02% |
10,667
| – | – |
|
|
MMP
527
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $2.76M | 0.02% |
39,004
+9,487
| +32% | +$677K |
|
528
Bloomin' Brands
BLMN
$680M
| $2.73M | 0.02% |
+158,584
| New | +$2.94M |
|
|
NBL
529
DELISTED
Noble Energy, Inc.
NBL
| $2.73M | 0.02% |
+76,502
| New | +$2.69M |
|
|
HMHC
530
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $2.69M | 0.02% |
200,908
-1,011,120
| -83% | -$15.8M |
|
|
CPAAU
531
DELISTED
Conyers Park Acquisition Corp. Unit
CPAAU
| $2.69M | 0.02% |
+250,000
| New | +$2.63M |
|
|
HOME
532
DELISTED
At Home Group Inc.
HOME
| $2.68M | 0.02% |
+176,934
| New | +$2.59M |
|
533
Green Plains
GPRE
$1.19B
| $2.66M | 0.02% |
+101,413
| New | +$2.37M |
|
534
Cadence Design Systems
CDNS
$90B
| $2.65M | 0.02% |
+103,797
| New | +$2.6M |
|
535
Acacia Research
ACTG
$450M
| $2.64M | 0.02% |
+404,642
| New | +$2.33M |
|
536
CNA Financial
CNA
$14.5B
| $2.63M | 0.02% |
76,359
+32,858
| +76% | +$1.07M |
|
|
PFNX
537
DELISTED
Pfenex Inc.
PFNX
| $2.62M | 0.02% |
292,445
| – | – |
|
538
Best Buy
BBY
$18B
| $2.6M | 0.02% |
+68,222
| New | +$2.39M |
|
539
Western Midstream Partners
WES
$19.6B
| $2.6M | 0.02% |
61,117
+36,092
| +144% | +$1.36M |
|
540
Cracker Barrel
CBRL
$1.2B
| $2.58M | 0.02% |
+19,510
| New | +$3M |
|
|
DCH
541
Dauch Corp
DCH
$1.3B
| $2.58M | 0.02% |
+149,804
| New | +$2.52M |
|
542
PPG Industries
PPG
$25.9B
| $2.57M | 0.02% |
+24,842
| New | +$2.61M |
|
543
Antero Resources
AR
$10.9B
| $2.54M | 0.02% |
94,431
+57,172
| +153% | +$1.52M |
|
544
ICU Medical
ICUI
$3.93B
| $2.54M | 0.02% |
20,120
-115,336
| -85% | -$13.9M |
|
545
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $2.54M | 0.02% |
+60,025
| New | +$2.46M |
|
546
BlackBerry
BB
$5.01B
| $2.52M | 0.02% |
+316,478
| New | +$2.38M |
|
|
QPACU
547
DELISTED
Quinpario Acquisition Corp. 2 Unit
QPACU
| $2.52M | 0.02% |
250,000
| – | – |
|
|
LOGM
548
DELISTED
LogMein, Inc.
LOGM
| $2.5M | 0.02% |
27,656
-188,281
| -87% | -$15.1M |
|
549
Autoliv
ALV
$8.6B
| $2.49M | 0.02% |
+32,410
| New | +$2.49M |
|
550
Knowles
KN
$3.22B
| $2.48M | 0.02% |
+176,198
| New | +$2.49M |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.